Case Studies

Contingent Consideration Valuation

Contingent Consideration Valuation

THE CLIENT AND THE ASK: A pharmaceutical company (the “Acquirer”) acquired a biotechnology company (the “Company”) in exchange for an upfront payment and certain payments contingent upon successful achievement of future regulatory and sales milestones for certain...

Forecasting and Valuation

Forecasting and Valuation

THE COMPANY AND THE ASK: The Company is a technology company with a business proposition to provide diagnostic services to rural India and reduce the turnaround time of getting the report from 24 hours to 1 hour. The Company was operating using multiple business...

IRC – 409A Valuation of Common Stock

IRC – 409A Valuation of Common Stock

THE COMPANY: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...

ASC – 815 Valuation of Complex Securities

ASC – 815 Valuation of Complex Securities

Instruments Complex securities and embedded derivatives such as convertible debt, profit interests, preferred warrants, purchase options, securities that have unique characteristics, as mentioned below. Characteristics (indicative list) Warrants convertible in next...

ASC – 805 Purchase Price Allocation

ASC – 805 Purchase Price Allocation

THE DEAL: Company A / The Acquirer (Company): The acquirer is a provider of interactive technology products like large-format displays and collaboration software. Company B / The Target: The target company develops software applications for use with multi-touch...

Contact Us
Linkedin
Instagram